ACET Logo

Adicet Bio, Inc. (ACET) 

NASDAQ
Market Cap
$79.38M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
39 of 963
Rank in Industry
31 of 552

Largest Insider Buys in Sector

ACET Stock Price History Chart

ACET Stock Performance

About Adicet Bio, Inc.

Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also engages in the development of ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors. Adicet Bio, Inc. is based in Boston, Massachusetts.

Insider Activity of Adicet Bio, Inc.

Over the last 12 months, insiders at Adicet Bio, Inc. have bought $15M and sold $8,437 worth of Adicet Bio, Inc. stock.

On average, over the past 5 years, insiders at Adicet Bio, Inc. have bought $10.89M and sold $4.82M worth of stock each year.

Highest buying activity among insiders over the last 12 months: ORBIMED ADVISORS LLC () — $322.5M. GORDON CARL L () — $97.5M.

The last purchase of 3,125,000 shares for transaction amount of $7.5M was made by ORBIMED ADVISORS LLC () on 2024‑01‑25.

List of Insider Buy and Sell Transactions, Adicet Bio, Inc.

2024-06-05Saledirector
5,900
0.0071%
$1.43$8,437-2.78%
2024-01-25Purchase
3.13M
7.0488%
$2.40$7.5M-39.68%
2024-01-25Purchase
3.13M
7.0488%
$2.40$7.5M-39.68%
2023-10-02PurchasePresident & CEO
5,500
0.013%
$1.33$7,340+15.27%
2023-09-29SalePresident & CEO
5,500
0.0127%
$1.36$7,481+10.22%
2023-09-28SalePresident & CEO
5,500
0.0128%
$1.42$7,810+6.34%
2023-09-28PurchasePresident & CEO
5,500
0.0128%
$1.42$7,810+6.34%
2023-06-30Purchasedirector
5,000
0.0115%
$2.40$12,000-27.98%
2023-06-27Purchase
875,000
1.9987%
$2.09$1.83M-16.90%
2023-06-27Purchase
875,000
1.9987%
$2.09$1.83M-16.90%
2023-02-15SaleChief Technology Officer
4,533
0.0101%
$7.57$34,327-67.81%
2023-02-10SaleChief Technology Officer
10,467
0.0247%
$7.98$83,476-67.94%
2022-11-10SalePresident & CEO
39,955
0.095%
$20.30$811,242-72.55%
2022-11-10SaleChief Scientific Officer
6,967
0.0171%
$21.00$146,307-72.55%
2022-11-07SalePresident & CEO
30,000
0.0726%
$19.05$571,488-69.89%
2022-11-03SalePresident & CEO
24,813
0.06%
$18.04$447,718-68.13%
2022-11-02SalePresident & CEO
500
0.0013%
$18.00$9,000-66.31%
2022-10-19SaleChief Scientific Officer
8,067
0.0198%
$16.27$131,250-62.10%
2022-10-12SaleChief Scientific Officer
1,646
0.0039%
$15.40$25,348-61.34%
2022-09-14SalePresident & CEO
952
0.0023%
$18.00$17,136-57.90%

Insider Historical Profitability

<0.0001%
ORBIMED ADVISORS LLC
7526359
9.1338%
$0.9630<0.0001%
GORDON CARL L
7526359
9.1338%
$0.9620<0.0001%
Kauffman Michaeldirector
5900
0.0072%
$0.9601
SILVERSTEIN JONATHAN
4830387
5.862%
$0.9610
PureTech Health LLC10 percent owner
2119696
2.5724%
$0.9616
Sinclair Andrewdirector
2115385
2.5672%
$0.9610<0.0001%
Jakobovits Aya
356343
0.4324%
$0.96010
Healey DonChief Technology Officer
66568
0.0808%
$0.9602
Galimi FrancescoSVP & Chief Medical Officer
59917
0.0727%
$0.9601
Schor ChenPresident & CEO
43469
0.0528%
$0.96518
Aftab BlakeChief Scientific Officer
28209
0.0342%
$0.9606
DUBIN STEVEdirector
10900
0.0132%
$0.9610<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
OrbiMed$26.9M13.9311.45M+37.55%+$7.34M0.21
RA Capital Management, L.P.$17.72M9.187.54MNew+$17.72M0.02
Tang Capital Management, LLC$15.06M7.86.41M+631.14%+$13M0.06
Balyasny Asset Management Llc$14.53M7.526.18MNew+$14.53M0.04
RTW Investments, LP$9.72M5.034.13M0%+$00.15
Millennium Management LLC$9.65M54.11M+210.7%+$6.54M0.01
Morgan Stanley$9.56M4.954.07M+45.32%+$2.98M<0.01
Goldman Sachs$9.41M4.884.01M+13,899.19%+$9.35M<0.01
BlackRock$7.93M4.113.37M+54.55%+$2.8M<0.0001
The Vanguard Group$7.35M3.813.13M+85.55%+$3.39M<0.0001
The Carlyle Group$6.9M3.592.95M+39.39%+$1.95M0.3
Commodore Capital, LP$3.23M1.671.37MNew+$3.23M0.01
Blackstone$2.91M1.511.24MNew+$2.91M0.01
Geode Capital Management$2.83M1.471.2M+82.08%+$1.28M<0.0001
Schonfeld Group$2.67M1.381.13M+466.92%+$2.2M0.02
Renaissance Technologies$2.46M1.281.05M+36.84%+$663,599.62<0.01
State Street$2.21M1.14940,234+46.79%+$704,273.88<0.0001
Cowen Group$2.02M1.05860,143-68.32%-$4.36M0.07
Octagon Capital Advisors LP$1.8M0.93767,799New+$1.8M0.01
Woodline Partners LP$1.73M0.9735,095New+$1.73M0.02
Alyeska Investment Group L P$1.54M0.8655,665New+$1.54M0.01
DAFNA Capital Management, LLC$1.41M0.73600,000New+$1.41M0.03
Two Sigma$1.23M0.64521,571+44.59%+$377,988.15<0.01
Two Sigma Advisers LP$1.19M0.62506,039-2.69%-$32,900.01<0.01
Northern Trust$1.02M0.53435,615+87.7%+$478,295.85<0.0001
Connor Clark & Lunn Investment Management Ltd$978,291.000.51416,294New+$978,291.00<0.01
Nuveen$964,994.000.5410,636+111.88%+$509,554.88<0.0001
Johnson & Johnson$856,509.000.44364,472-47.07%-$761,688.870.02
Acadian Asset Management$834,000.000.43355,343-36.52%-$479,748.97<0.01
Silverarc Capital Management Llc$778,506.000.4331,279New+$778,506.000.01
D. E. Shaw & Co.$765,980.000.4325,949-5.96%-$48,574.49<0.01
Atom Investors Lp$609,371.000.32259,307New+$609,371.000.04
Citadel Advisors LLC$559,803.000.29238,214+78.8%+$246,714.79<0.0001
Xtx Topco Ltd$531,215.000.28226,049+882.78%+$477,162.660.01
Fidelity Investments$456,372.000.24194,201+42.88%+$136,974.35<0.0001
Dimensional Fund Advisors$444,919.000.23189,327+23.41%+$84,395.65<0.0001
Charles Schwab$352,679.000.18150,076+116.06%+$189,447.82<0.0001
BNY Mellon$343,221.000.18146,052+49.74%+$114,005.15<0.0001
Stonepine Capital Management Llc$332,638.000.17141,548New+$332,638.000.02
Exchange Traded Concepts, LLC$326,634.000.17138,993+69.53%+$133,966.640.01
Bridgeway Capital Management$305,030.000.16129,800+136.86%+$176,250.00<0.01
Qube Research & Technologies$256,716.000.13109,241New+$256,716.00<0.0001
Prudential Financial$251,920.000.13107,200+79.72%+$111,742.50<0.0001
Bank of America$239,697.000.12101,999+113.64%+$127,501.25<0.0001
American Century Investments$145,444.000.0861,891New+$145,444.00<0.0001
RhumbLine Advisers$142,157.000.0760,496+28.4%+$31,443.45<0.0001
JPMorgan Chase$139,221.000.0759,243+198.75%+$92,620.52<0.0001
Jane Street Capital$137,686.000.0758,590+154.61%+$83,608.00<0.0001
UBS$125,814.000.0753,538+137.13%+$72,755.83<0.0001
Cubist Systematic Strategies$107,992.000.0645,954+135.24%+$62,084.71<0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.